Protective effects of pentadecapeptide BPC 157 on gastric ulcer in rats

AIM: To investigate the protective effects of gastric pentadecapeptide BPC 157 on acute and chronic gastric ulcers in rats and to compare the results in therapy of human gastric ulcers by different administration methods. METHODS: Gastric pentadecapeptide BPC 157 was administered (initial single or continuous administration) into rats either intragastrically or intramuscularly before (induced acute gastric ulcer) or after (induced chronic gastric ulcer) the applications of inducing agents, and each animal was sacrificed to observe the protective effects of BPC 157 on gastric ulcers. RESULTS: Both intramuscular (im) and intragastric (ig) administration of BPC 157 could apparently reduce the ulcer area and accelerate the healing of induced ulcer in different models and the effect of im administered BPC 157 was better than that of ig. The rats treated with higher dosages (400 ng/kg, 800 ng/kg) of BPC 157 (im and ig) showed significantly less lesion (P<0.01 vs excipient or saline control), the inhibition ratio of ulcer formation varied between 45.7% and 65.6%, from all measurements except 400 ng/kg BPC 157 in pylorus ligation induced model (P<0.05), in which the inhibition rate was 54.2%. When im administered (800 ng/kg BPC 157) in three modeis, the inhibition ratio of ulcer formation was 65.5%, 65.6% and 59.9%, respectively, which was better than that of famotidine (its inhibition rate was 60.8%, 57.2% and 34.3%, respectively). Continuous application of BPC 157 (in chronic acetate induced gastric ulcer) could accelerate rebuilding of glandular epithelium and formation of granulation tissue (P<0.05 at 200 ng/kg and P<0.01 at 400 ng/kg and 800 ng/kg vs excipient or saline control). CONCLUSION: Both im and ig administered gastric pentadecapeptide BPC 157 can apparently ameliorate acute gastric ulcer in rats and antagonize the protracted effect of acetate challenge on chronic ulcer. The effect of im administration of BPC 157 is better than that of ig, and the effective dosage of the former is lower than that of the latter.

Bending analysis of magnetoelectroelastic nanoplates resting on Pasternak elastic foundation based on nonlocal theory

Based on the nonlocal theory and Mindlin plate theory,the governing equations(i.e.,a system of partial differential equations(PDEs)for bending problem)of magnetoelectroelastic(MEE)nanoplates resting on the Pasternak elastic foundation are first derived by the variational principle.The polynomial particular solutions corresponding to the established model are then obtained and further employed as basis functions with the method of particular solutions(MPS)to solve the governing equations numerically.It is confirmed that for the present bending model,the new solution strategy possesses more general applicability and superior flexibility in the selection of collocation points.The effects of different boundary conditions,applied loads,and geometrical shapes on the bending properties of MEE nanoplates are evaluated by using the developed method.Some important conclusions are drawn,which should be helpful for the design and applications of electromagnetic nanoplate structures.

The Expression of vasa Gene during Zebrafish (Danio rerio) Oogenesis

vasa gene expression pattern during oogenesis of zebrafish was examined usingin situ hybridization and fluorescent quantitative RT-PCR. During zebrafish oogensis,vasa mRNA is expressed strongly and uniformly distributed in the cytoplasm in stage II oocytes, followed by a distribution among vacuome in stage III. Later in stage IV and V,vasa mRNA is enriched at the cortex and finally localized at the cortex. The fluorescent quantitative RT-PCR shows that the quantity ofvasa mRNA decreases from stage II to stage III, but remains relatively invariable from stage III to stage V. The observed differences invasa mRNA expression in the different stages of zebrafish oogenesis suggest thatvasa gene plays an important role during oogenesis. Key words vasa - zebrafish - fluorescent quantitative RT-PCR - oogenesis CLC number Q 952.6 Foundation item: Supported by the National Natural Science Foundation of China (30370744, 30150005)Biography: XIANG Fang (1979-), male, Master candidate, research direction: molecular development of animals.